Archynetys
  • Home
  • Economy
  • Entertainment
  • Health
  • News
  • Sports
  • Technology and Science
  • World
Tag:

NSCLC

  • Health

    Byoung Chul Cho, MD, PhD – Profile | Expertise

    by Archynetys Health Desk September 9, 2025
    by Archynetys Health Desk September 9, 2025

    Captions are auto-generated. An enhanced dermatologic management (DM) strategy, COCOON DM, significantly reduced the incidence and …

    Read more
    0 FacebookTwitterPinterestEmail
  • Health

    Cemiplimab: 5-Year Survival in Advanced NSCLC with High PD-L1

    by Archynetys Health Desk September 8, 2025
    by Archynetys Health Desk September 8, 2025

    Cemiplimab monotherapy provided durable survival benefits compared with chemotherapy for people with advanced non–small cell lung …

    Read more
    0 FacebookTwitterPinterestEmail
  • Health

    EGFR-Mutated NSCLC Treatments: Current & Future Options

    by Archynetys Health Desk September 8, 2025
    by Archynetys Health Desk September 8, 2025

    Uncommon EGFR mutations, such as exon 20 insertions, compound variants, and P-loop αC-helix compressing (Pacc) alterations, …

    Read more
    0 FacebookTwitterPinterestEmail
  • Economy

    Osimertinib & Chemo After Progression: Improved PFS in EGFR+ NSCLC

    by Archynetys Economy Desk September 6, 2025
    by Archynetys Economy Desk September 6, 2025

    Osimertinib Plus Chemo in EGFR-Mutated NSCLC | Image Credit: © Ashling Wahner & MJH Life Sciences …

    Read more
    0 FacebookTwitterPinterestEmail
  • Health

    Iza-Bren: FDA Breakthrough Therapy for NSCLC

    by Archynetys Health Desk August 31, 2025
    by Archynetys Health Desk August 31, 2025

    The FDA granted a breakthrough therapy designation to izalontamab brengitecan (iza-bren, formerly BL-B01D1; Bristol Myers Squibb, …

    Read more
    0 FacebookTwitterPinterestEmail
  • Health

    NSCLC Testing & Patient Engagement: Dr. Rotow on Comprehensive Care

    by Archynetys Health Desk August 27, 2025
    by Archynetys Health Desk August 27, 2025

    In part 2 of an interview with The American Journal of Managed Care®Julia Rotow, MD, Dana-Farber …

    Read more
    0 FacebookTwitterPinterestEmail
  • Health

    5 Hot FDA Approval Dates That Made Waves Across Therapeutic Areas in July

    by Archynetys Health Desk August 8, 2025
    by Archynetys Health Desk August 8, 2025

    The FDA maintained its momentum in July, issuing a wave of drug approvals across diverse therapeutic …

    Read more
    0 FacebookTwitterPinterestEmail
  • Health

    NSCLC Chemotherapy: Predictive Assay Identifies Ideal Candidates

    by Archynetys Health Desk May 31, 2025
    by Archynetys Health Desk May 31, 2025

    “`html Biomarker Testing Improves Outcomes in Early-Stage Lung cancer Biomarker testing Substantially Improves Outcomes in Early-Stage …

    Read more
    0 FacebookTwitterPinterestEmail

Recent Posts

  • su familia pide ayuda y Jaime sí se presentará en Medellín

    May 7, 2026
  • Ryan Cohen’s mysterious bank letter backing his eBay bid reveals a big issue

    May 7, 2026
  • Anti-DDoS Firm Heaped Attacks on Brazilian ISPs – Krebs on Security

    May 7, 2026
  • Raja Jackson Reaches Plea Deal After Alleged In-Ring Assault

    May 7, 2026
  • Amber Rose ‘Partially’ to Blame for Kanye, Taylor Swift Drama

    May 7, 2026
  • Dentist Bacau
Archynetys
  • Home
  • Economy
  • Entertainment
  • Health
  • News
  • Sports
  • Technology and Science
  • World